| 2003 |
BPGAP1/ARHGAP8 selectively enhanced RhoA GTPase activity in vivo, and formed homophilic or heterophilic complexes with other BCH domain-containing proteins via pull-down and co-immunoprecipitation. Pseudopodia formation required both the BCH and GAP domains but not the proline-rich region, while enhanced cell migration required the proline-rich region. Constitutively active RhoA, or dominant-negative Cdc42 and Rac1, differentially inhibited pseudopodia formation. |
In vivo GAP activity assay, pull-down, co-immunoprecipitation, deletion mutant fluorescence microscopy, dominant-negative/constitutively-active GTPase co-expression |
The Journal of biological chemistry |
High |
12944407
|
| 2004 |
BPGAP1/ARHGAP8 directly interacts with cortactin via its proline-rich motif 182-PPPRPPLP-189 binding to the SH3 domain of cortactin, both in vitro and in vivo. Together they co-localize to the cell periphery and enhance cell migration. Alanine substitution of prolines at positions 184 and 186 abolished the interaction, prevented cortactin translocation to the periphery, and eliminated enhanced cell migration. |
Protein precipitation, MALDI mass spectrometry, co-immunoprecipitation, deletion/point-mutant analysis, fluorescence co-localization, cell migration assay |
Molecular biology of the cell |
High |
15064355
|
| 2004 |
BPGAP1/ARHGAP8 contains a C-terminal RhoGAP domain, a central SH3-binding proline-rich motif, and an N-terminal BCH/Sec14p-like domain, sharing identical genomic organization with ARHGAP1/CDC42GAP/p50RHOGAP. Three alternatively spliced transcripts differ only in the BCH/Sec14p-like domain region. |
Genomic cloning, sequence analysis, domain characterization, RT-PCR, PCR-SSCP |
Gene |
Medium |
15225876
|
| 2005 |
BPGAP1/ARHGAP8 interacts directly with EEN/endophilin II via the SH3 domain of EEN binding to the proline-rich region 182-PPPRPPLP-189 of BPGAP1, with prolines 184 and 186 being indispensable. Overexpression of EEN together with wild-type BPGAP1 enhanced EGF-stimulated receptor endocytosis and ERK1/2 phosphorylation; a catalytically inactive GAP domain mutant of BPGAP1 blocked both EGF receptor endocytosis and ERK1/2 augmentation, indicating the GAP activity is required. |
Protein precipitation, MALDI mass spectrometry, pull-down, co-immunoprecipitation, deletion/point-mutant analysis, receptor endocytosis assay, ERK1/2 phosphorylation assay |
Journal of cell science |
High |
15944398
|
| 2010 |
The RhoGAP domain of BPGAP1/ARHGAP8 interacts with the peptidyl-prolyl isomerase Pin1, leading to enhanced GAP activity toward RhoA. Active Mek2 (but not kinase-dead Mek2) acts as a scaffold to bridge Pin1 and BPGAP1, releasing autoinhibition of the proline-rich motif 186-PPLP-189 and making non-canonical motifs 186-PPLP-189 and 256-DDYGD-260 accessible for concerted binding by the WW and PPI domains of Pin1. Pin1 knockdown caused super-induction of BPGAP1-induced acute ERK activation after EGF stimulation; re-introducing wild-type but not catalytic or non-binding Pin1 mutants reversed this and inhibited cell migration induced by BPGAP1 and active Mek2. |
Co-immunoprecipitation, domain deletion/point-mutant analysis, Pin1 knockdown/rescue, kinase-dead Mek2 mutant, ERK activation assay, cell migration assay |
Journal of cell science |
High |
20179103
|
| 2012 |
The BCH domain of BPGAP1/ARHGAP8 specifically targets K-Ras to induce robust ERK activation and PC12 cell differentiation/neuritogenesis. This effect was inhibited by dominant-negative Mek2 (K101A) and dominant-negative K-Ras (S17N), and also by SmgGDS. SmgGDS knockdown super-induced K-Ras activation and PC12 differentiation mediated by the BCH domain. |
Domain deletion/mutant expression, dominant-negative GTPase and kinase constructs, SmgGDS siRNA knockdown, ERK activation assay, PC12 differentiation assay |
Molecular biology of the cell |
High |
23155002
|
| 2017 |
BPGAP1/ARHGAP8 promotes MP1-induced ERK activation on late endosomes by scaffolding the MP1/MEK1 complex. This scaffolding function requires phosphorylation of BPGAP1 by JNK at Ser424 in the C-terminal tail, which unlocks its autoinhibitory conformation. Phosphorylated BPGAP1 facilitates endosomal ERK signaling transduction to the nucleus, driving cell proliferation and transformation via the ERK-Myc-CyclinA axis. |
Protein interaction studies, phosphorylation site mutagenesis (Ser424), endosomal fractionation, ERK signaling assays, cell proliferation/transformation assays, Rab GTPase screen |
Oncogene |
High |
28092672
|
| 2023 |
ARHGAP8/BPGAP1 binds inactive Rac1 and localizes to lamellipodia. Under EGF stimulation, BPGAP1 recruits the RacGEF Vav1 to activate Rac1, promoting polarized cell motility, spreading, invadopodium formation, and cell extravasation. BPGAP1 simultaneously down-regulates local RhoA activity via its RhoGAP domain, and this RhoA inactivation influences Rac1 binding to BPGAP1 and its subsequent activation by Vav1. Thus BPGAP1 acts as a dual-function scaffold coordinating Rac1 activation and RhoA inactivation. |
Co-immunoprecipitation (Rac1, Vav1, BPGAP1), live-cell fluorescence imaging, lamellipodia localization, RhoA/Rac1 activity assays, invadopodium formation assay, cell extravasation assay, domain deletion analysis |
Molecular biology of the cell |
High |
36598812
|
| 2026 |
ARHGAP8 localizes to excitatory synapses in hippocampal neurons, with synaptic localization linked to the NMDA receptor subunit GluN2B. Increasing ARHGAP8 levels reduced dendritic complexity and spine volume, and caused a significant decrease in synaptic AMPA receptor-mediated transmission. |
Neuronal overexpression, synaptic localization imaging, co-localization with GluN2B, spine morphology analysis, electrophysiology (AMPA receptor-mediated transmission) |
Communications biology |
Medium |
41862576
|
| 2025 |
ARHGAP8 suppresses RhoA activity but activates ROCK2 through RhoB/C-mediated compensatory mechanisms (noncanonical pathway). Hyperactivation of ROCK2 via this pathway disrupts actin cytoskeletal remodeling, increases immature dendritic spines, and causes synaptic ultrastructural defects. In vivo, this regulatory axis links the lncRNA THUMPD3-AS1 and miR-485-5p to ARHGAP8-driven synaptic pathology. |
In vivo overexpression (ventral hippocampus), RhoA/ROCK2 activity assays, miRNA sponge/knockdown experiments, dendritic spine imaging, synaptic ultrastructure electron microscopy |
Advanced science |
Medium |
41168987
|